Xiao-Fang Xing
Overview
Explore the profile of Xiao-Fang Xing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo T, Tang X, Gao X, Zhou Y, Jin B, Deng Z, et al.
Mol Cancer
. 2022 Dec;
21(1):216.
PMID: 36510184
At present, there is no validated marker to identify the subpopulation of patients with advanced gastric cancer (AGC) who might benefit from neoadjuvant chemotherapy (NACT). In view of this clinical...
2.
Wang G, Huangfu L, Gao X, Gan X, Xing X, Ji J
Front Oncol
. 2022 Jun;
12:887244.
PMID: 35656510
Background: Transcription factors (TFs) play a crucial role in tumorigenesis and anti-tumor immunity. However, the potential role of large-scale transcription factor regulation patterns in the progression in gastric cancer (GC)...
3.
Tang X, Guo T, Gao X, Wu X, Xing X, Ji J, et al.
Mol Cancer
. 2021 Jul;
20(1):99.
PMID: 34330299
Exosomes are a subpopulation of the tumour microenvironment (TME) that transmit various biological molecules to promote intercellular communication. Exosomes are derived from nearly all types of cells and exist in...
4.
Guo T, Bai Y, Cheng X, Han H, Du H, Hu Y, et al.
Cancer Commun (Lond)
. 2021 Feb;
41(3):258-272.
PMID: 33570246
Background: Insulin gene enhancer protein 1, (ISL1), a LIM-homeodomain transcription factor, is involved in multiple tumors and is associated with insulin secretion and metabolic phenotypes. However, the role of ISL1...
5.
Bian W, Xue F, Wang L, Xing X
Cancer Manag Res
. 2021 Feb;
13:633-642.
PMID: 33531835
Aim: A series of research reveal that circular RNA (circRNA) plays a vital role in regulating the development of tumor cells. In this research, we would explore the role and...
6.
Guo T, Wen X, Li Z, Han H, Zhang C, Bai Y, et al.
Cell Death Dis
. 2019 Jan;
10(2):33.
PMID: 30674889
ISL1, a LIM-homeodomain transcription factor, serves as a biomarker of metastasis in multiple tumors. However, the function and underlying mechanisms of ISL1 in gastric cancer (GC) have not been fully...
7.
Ma Y, Xing X, Dong B, Cheng X, Guo T, Du H, et al.
Cancer Manag Res
. 2018 Nov;
10:4969-4980.
PMID: 30464597
Background: Glucose-6-phosphate isomerase (GPI) is a glycolytic-related enzyme that inter-converts glucose-6-phosphate and fructose-6-phosphate in the cytoplasm. This protein is also secreted into the extracellular matrix by cancer cells and is,...
8.
Xie M, Dart D, Guo T, Xing X, Cheng X, Du H, et al.
Gastric Cancer
. 2017 May;
21(1):41-54.
PMID: 28493075
Background: We recently reported that miR-1 was one of the most significantly downregulated microRNAs in gastric cancer (GC) patients from The Cancer Genome Atlas microRNA sequencing data. Here we aim...
9.
Wang X, Du H, Li L, Shao D, Zhong X, Hu Y, et al.
Oncol Lett
. 2017 Jan;
13(1):222-230.
PMID: 28123545
S100A6 is involved in regulating the progression of cancer. S100A6 can regulate the dynamics of cytoskeletal constituents, cell growth and differentiation by interacting with binding or target proteins. The present...
10.
Li L, Wen X, Bu Z, Cheng X, Xing X, Wang X, et al.
Oncol Rep
. 2016 Mar;
35(5):3009-17.
PMID: 26986870
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) holds promise for cancer therapy due to its unique capacity to selectively trigger apoptosis in cancer cells. However, TRAIL therapy is greatly hampered by...